Expression of Src in breast cancer and its relationship with prognosis

Shiran Sun,Maimaiti Yusufu·,Yu Yan,Qiuyang Zhao,Changwen Wang,Tao Huang
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2016.01.064
2016-01-01
Abstract:Objective To explore Src expression and its effects on the prognosis of breast cancer.Methods We used immunohistochemistry to detect the Src expression in 262 cases of invasive breast cancer by tissue microarrays.The correlation between Src expression and clinicopathologic features were analyzed.Survival analysis and the Cox proportional hazards model were used to explore the prognostic value of Src expression in breast cancer.Results The Src expression rate in 262 cases of breast cancer was 47.3%.Src expression was significantly associated with lymph node metastasis and Her-2 expression (P <0.05 for both).The patients who exhibited Src expression demonstrated poor overall survival (OS) (P < 0.05).Subgroup analysis demonstrated that lymph node metastasis negative/Src positive patients and Luminal A/Src positive patients exhibited significantly worse OS (P <0.05,respectively).Multivariate analysis demonstrated that Src expression was an independent predictor of OS for patients with breast cancer.Conclusion Src expression predicts a poor prognosis in patients with breast cancer.For lymph node metastasis negative/Src positive patients and Luminal A/Src positive patients,Src inhibition therapy may be necessary to improve the poor prognosis.
What problem does this paper attempt to address?